Alkermes (STU:8AK) Construction In Progress: €21 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:8AK Alkermes PLC STU:8AK
65 GF Score
Price €46.42
GF Value €28.17
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Alkermes Construction In Progress?

Alkermes STU:8AK +0.32% 65 Construction In Progress is €21 Mil as of Mar. 2026. GuruFocus rates STU:8AK with a GF Score™ of 65/100 and a GF Value™ of €28.17 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Alkermes's quarterly construction in progress declined from Sep. 2025 (€42 Mil) to Dec. 2025 (€33 Mil) and declined from Dec. 2025 (€33 Mil) to Mar. 2026 (€21 Mil).

Alkermes's annual construction in progress increased from Dec. 2023 (€42 Mil) to Dec. 2024 (€56 Mil) but then declined from Dec. 2024 (€56 Mil) to Dec. 2025 (€33 Mil).

Alkermes Construction In Progress Historical Data

* Premium members only.

The historical data trend for Alkermes's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alkermes Construction In Progress Chart

Alkermes Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 76.56 73.65 41.99 55.76 33.13

Alkermes Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.12 41.85 33.13 20.61 0.00
STU:8AK
65GF Score
Alkermes PLC STU:8AK
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alkermes Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of €21 Mil mean?
Alkermes (STU:8AK) has a Construction In Progress of €21 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Alkermes and its competitors.
Is Alkermes' Construction In Progress too high?
Alkermes' current Construction In Progress is €21 Mil. Overall, Alkermes has a GF Score™ of 65/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Alkermes' Construction In Progress compare to LQDA and LNTH?
Alkermes' Construction In Progress of €21 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Alkermes and its competitors. Alkermes's current Construction In Progress is €21 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alkermes stock overvalued right now?
Based on GuruFocus' analysis, Alkermes (STU:8AK) is currently considered Significantly Overvalued. The stock's GF Value™ is €28.17, compared to a current price of €46.42 — trading 64.8% above its estimated fair value. The current Construction In Progress is €21 Mil. Alkermes' overall GF Score™ is 65/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Alkermes (STU:8AK), the current Construction In Progress is €21 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alkermes (STU:8AK) Overvalued in 2026?

Based on GuruFocus' analysis, Alkermes stock appears to be overvalued. The current stock price of €46.42 is trading 64.8% above its estimated GF Value™ of €28.17. GuruFocus considers Alkermes to be Significantly Overvalued.

Key valuation signals for STU:8AK:

  • Construction In Progress: €21 Mil
  • GF Value™: €28.17 vs. price of €46.42 (64.8% above fair value)
  • GF Score™: 65/100 with 8 warning signs

No single metric tells the full story. See the STU:8AK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alkermes Business Description

Other Exchanges ALKS:USA8AK:Germany
Address 1 Burlington Road, Connaught House, Dublin, IRL, D04 C5Y6
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
65GF Score

Get the complete analysis for STU:8AK

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€46.42
Price
€28.17
GF Value